MED12 and Uterine leiomyoma: To assess whether exon 2 mutations at glycine 44 of MED12 result in a loss of CDK8 chromatin binding in uterine leiomyomas, ChIP-seq of CDK8 and MED12 was performed (Supplementary Table 1 and Supplementary Fig. 7a, c).